Protective effect of nitric oxide in an endotoxin-induced septic shock

American Journal of Surgery

Volumn 171, Issue 3, 1996, Pages 340-345

  Park, Joo Hung ^a   Chang, Shun Hee ^a   Lee, Kwang Min ^a   Shin, Sung Hye ^a  

^a Presbyterian Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; N(G) NITRO DEXTRO ARGININE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0029865958     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)89638-9     Document Type: Article

References (27)

1. Parrillo JE. Pathogenic mechanisms of septic shock. NEJM. 1993;328:1471-1477.
2. Lloyd SS, Chang AK, Taylor FB, et al. Free radicals and septic shock in primates: the role of tumor necrosis factor. Free Radical Biol Med. 1993;14:233-242.
3. Busund R, Lindsetmo RO, Rasmussen LT, et al. Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. Arch Surg. 1991;126:591-597.
4. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
5. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med. 1994;120:227-237.
6. Kilbourn RG, Gross SS, Jubran A, et al. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA. 1990;87:3629-3632.
7. Salvemini D, Korbut R, Anggard E, Vane J. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA. 1990;87: 2593-2597.
8. Kilbourn RG, Jubran A, Gross SS, et al. Reversal cf endotoxin-mediated shock by NG-Methyl-L-Arginine, an inhibitor of nitric oxide synthase. Biochem Biophys Res Commun. 1989;172:1132-1138.
9. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991;338:1557-1558.
10. Billiar TR, Curran RD, Harbrecht BG, et al. Modulation of nitrogen oxide synthesis in vivo: NG-Monomethyl-L-Arginine inhibits endotoxin- induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol. 1990;48:565-569.
11. Cobb JP, Natanson C, Hoffman WD, et al. N -amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med. 1992;176:1175-1182.
12. Minnard EA, Shou J, Naama H, et al. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg. 1994;129:142-147.
13. 2+-independent nitric oxide synthases. FEBS Lett. 1991;291:145-149.
14. Liu S, Adcock IM, Old RW, et al. Lipopolysaccharide treatment in vivo induces widespread tissue expression of indue ible nitric oxide synthase mRNA. Biochem Biophys Res Commun. 1993;196:1208-1213.
15. Osterloh J, Goldfield D. Determination of nitrate and nitrite ions in human plasma by ion exchange-high performance liquid chromatography. J Liq Chromatogr. 1984;7:753-763.
16. Palacios M, Knowles RG, Palmer RMJ, Moncada S. Nitric oxide from L-Arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophys Res Commun. 1989;165:802-809.
17. Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenic factor in autoimmunity. Immunol Today. 1992;13:157-160.
18. Xie QW, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992;256:225-228.
19. Geller DA, Nussler AK, Silvio MD, et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Nad Acad Sci USA. 1993;90:522-526.
20. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA. 1992;89:6711-6715.
21. Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA. 1993;90:3024-3027.
22. Kaplan SS, Billiar T, Curran RD, et al. Inhibition of chemotaxis with NG-Monomethyl-L-Arginine: a role for cyclic GMP. Blood. 1989;74:1885-1887.
23. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Nad Acad Sci USA. 1991;88: 4651-4655.
24. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 1991;214:621-626.
25. Vespasiano MC, Lewandoski JR, Zimmerman JJ. Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shock. Crit Care Med. 1993;21:666-672.
26. Rubanyi GM, Ho EH, Cantor EH, et al. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun. 1991;181:1392-1397.
27. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA, 1990;87: 1620-1624.